20_Marth - Teva Pharmaceuticals_3.27.2013.pdf - The Wharton School at the University of Pennsylvania Bill Marth Teva Pharmaceuticals A global operations

20_Marth - Teva Pharmaceuticals_3.27.2013.pdf - The Wharton...

This preview shows page 1 - 11 out of 36 pages.

The Wharton School at the University of Pennsylvania Bill Marth, Teva Pharmaceuticals March 27, 2013
Image of page 1
Teva: we make quality healthcare accessible around the world A global operations network CZECH Opava Galena IRELAND Waterford UK Eastbourn e Runcorn HUNGARY Debrecen Debrecen API Godollo Sajobabony PERU San Miguel, Lima Ate, Lima Miraflores, Lima CHILE Maipu, Santiago ARGENTINA Munro, Buenos Aires ISRAEL Kfar Sava Jerusalem OSD Jerusalem MDP Ashdod Migada CANADA Stouffville 30 Novo Hood Rd . U.S. Irvine, CA NETHERLANDS Haarlem FR A NCE Sens Nevers Monaco MEXICO Xochimilc oToluca CROATIA Zagreb Savski Marof POLAND Kutno Krakow U.S. Sellersville, PA Fairfield, NJ Doral, FL N. Tonawanda, NY Pomona, NY Forest, VA Cincinnati, OH Salt Lake City, UT Minneapolis, MN Greensboro, NC Phoenix, AZ SPAIN Zaragoza St. Joseph,MO TAH INDIA Gajraula Malanpur Goa *Ahmedabad GERMANY Weiler Ulm CHINA Hangzhou Kunming (JV) Tianjin (JV) Netanya Beer Sheva ITALY Villanteri oSettimo Caronno Bulciago Rho Santhia Mexico, MO Toluca JAPAN Koka Takayama Kasukabe Minakuchi PUERTO RICO Guayama Humacao LITHUANIA Vilnius 54 Pharma sites 25 Countries 21 API sites RUSSIA *Yaroslav * Under construction 2
Image of page 2
Growth drivers CNS Respiratory High-value generics NTEs (New therapeutic entity) MS PD Oncology Respiratory Women’s Health Branded generics High-value generics OTC (over the counter) MS Branded generics Branded generics Respiratory Women’s Health MS OTC (over the counter) MS Generics Branded generics 3
Image of page 3